- 101. Immediate postpartum manual replacement of inverted uterus
- [ ] (UMLS (ICD9CM) C0490068) =Therapeutic or Preventive Procedure
| - 151. Immunoassay, qualitative, single step
- [Immunoassay, qualitative, single step ( HL7V3.0 )] (UMLS (HL7) C0523401) =Laboratory Procedure =ObservationMethod;
|
- 102. Immerse (Soak) Body Part
- (UMLS (HL7) C0694633) =Functional Concept =drug administration route;
| - 152. Immunoassay, semi-quantitative, multiple step
- [Immunoassay, semi-quantitative, multiple step ( HL7V3.0 )] (UMLS (HL7) C0523400) =Laboratory Procedure =ObservationMethod;
|
- 103. Immersion (soak)
- [Immersion (soak) ( HL7V3.0 )] (UMLS (HL7) C1553215) =Functional Concept =BodySurfaceRoute;
RouteByMethod | - 153. Immunoassay, semi-quantitative, single step
- [Immunoassay, semi-quantitative, single step ( HL7V3.0 )] (UMLS (HL7) C0523402) =Laboratory Procedure =ObservationMethod;
|
- 104. immersion foot
- [A condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. (Andrews' Diseases of the Skin, 8th ed, p27) ( MSH )] (UMLS (CSP) C0020941) =Injury or Poisoning =Foot Diseases;
| - 154. Immunoblastic Diffuse Large B-Cell Lymphoma PTLD
- (UMLS (NCI) C1334157) Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder;
Immunoblastic Lymphoma PTLD;
=Neoplastic Process ;
|
- 105. immigrant
- [person coming into a country of which he or she is not a native for the purpose of setting up residence. ( CSP )] (UMLS (CSP) C0282163) =Population Group =named group;
| - 155. Immunoblastic Lymphoma
- [A diffuse large B-cell lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, a prominent nucleolus, and abundant cytoplasm. ( NCI )] (UMLS (NCI) C0079746) =Neoplastic Process =histiocytic lymphoma;
Lymphoma, Diffuse;
High Grade Lymphoma;
|
- 106. immigration
- [ ] (UMLS (CSP) C0020942) =Activity
| - 156. Immunoblastic Lymphoma of the Thyroid
- [A diffuse large B-cell lymphoma variant, primarily involving the thyroid gland. It is composed predominantly of immunoblasts. (NCI05) ( NCI )] (UMLS (NCI) C1336752) Immunoblastic Lymphoma of the Thyroid Gland;
Immunoblastic Lymphoma of Thyroid;
Immunoblastic Lymphoma of Thyroid Gland;
Primary Thyroid Gland Immunoblastic Lymphoma;
Thyroid Gland Immunoblastic Lymphoma;
Thyroid Immunoblastic Lymphoma =Neoplastic Process ;
|
- 107. IMMOBILIZ/WOUND ATTN NEC
- [ ] (UMLS (ICD9CM) C0178032) =Therapeutic or Preventive Procedure
| - 157. immunoblotting
- [Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. ( MSH )] (UMLS (CSP) C0020985) =Laboratory Procedure ;
|
- 108. immobilization of body part
- [render a part of the body incapable of being moved, as by a cast or splint. ( CSP )] (UMLS (CSP) C0020944) =Therapeutic or Preventive Procedure =body movement;
| - 158. Immunochemiluminescence
- [Immunoassay, Chemiluminescent ( HL7V3.0 )] (UMLS (HL7) C1553181) =Laboratory Procedure =ObservationMethod;
|
- 109. immobilized enzyme
- [enzymes which are immobilized on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity; since they can be reused continuously, immobilized enzymes have found wide application in the industrial, medical and research fields. ( CSP )] (UMLS (CSP) C0014444) =Amino Acid, Peptide, or Protein; Enzyme; Indicator, Reagent, or Diagnostic Aid =enzyme;
| - 159. immunochemistry
- [field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues; includes physicochemical interactions between antigens and antibodies. ( CSP )] (UMLS (CSP) C0020986) =Biomedical Occupation or Discipline ;
=biochemistry;
|
- 110. immortalized cell
- [ ] (UMLS (CSP) C0178708) =Cell
| - 160. immunocompetence
- [The ability to produce a normal immune response. ( NCI )] (UMLS (NCI) C0020987) =Cell Function ;
|
- 111. ImmTher
- (UMLS (NCI) C0281671) =Organic Chemical; Pharmacologic Substance ;
| - 161. immunocompromised
- [Having a weakened immune system caused by certain diseases or treatments. ( NCI )] (UMLS (NCI) C0085393) =Finding
|
- 112. ImmTher/Indomethacin
- (UMLS (NCI) C0281699) =Therapeutic or Preventive Procedure
| - 162. Immunoconjugate, Ricin
- [A ricin-containing immunotoxin with immunotherapeutic property. Ricin, a plant toxin extracted from castor beans, inhibits protein synthesis via cleaving ribosomal subunit 28S rRNA. Ricin immunoconjugate consists of specific antibody conjugated with the blocked ricin (bR), which has the galactose-binding sites of the B-chain blocked while leaving the ribosome-inactivating ricin A-chain intact, thereby attains cell-type-specific immunotoxins. ( NCI )] (UMLS (NCI) C0280032) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 113. IMMU-4
- (UMLS (NCI) C0217156) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 163. immunocytochemistry
- [application of immunochemical techniques, as histochemical localization of immunoreactive substances using labeled antibodies as reagents, to cytochemistry. ( CSP )] (UMLS (CSP) C0242349) =Laboratory Procedure ;
=Cell/Tissue, Histochemistry;
immunologic technique;
staining;
=fluorescent antibody;
immunoperoxidase;
immunoelectron microscopy |
- 114. Immucyst
- (UMLS (NCI) C0255290) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
| - 164. Immunocytoma, Lymphoplasmacytic Type
- [plasma cell dyscrasia resembling leukemia, with cells of lymphocytic, plasmacytic, or intermediate morphology, that secrete an IgM monoclonal component. ( CSP )] (UMLS (NCI) C0024419) =Neoplastic Process ;
=Lymphoproliferative Disorder;
paraproteinemia;
gammopathy;
Vascular Hemostatic Disorders |
- 115. IMMUNDEF T-CELL DEF NOS
- [ ] (UMLS (ICD9CM) C1608262) Immunodeficiency with predominant T-cell defect, unspecified =Pathologic Function ;
| - 165. IMMUNODEFIC W HYPER-IGM
- [ ] (UMLS (ICD9CM) C0740331) Immunodeficiency with increased IgM =Disease or Syndrome ;
|
- 116. Immune
- [Protected against infectious disease by either specific or non-specific mechanisms. ( NCI )] (UMLS (NCI) C0439662) =Functional Concept
| - 166. Immunodeficiency Associated Burkitt Lymphoma
- (UMLS (NCI) C1334158) Immunodeficiency Associated Burkitt's Lymphoma;
Immunodeficiency Related Burkitt Lymphoma;
Immunodeficiency Related Burkitt's Lymphoma;
Immunodeficiency-Associated Burkitt Lymphoma;
Immunodeficiency-Associated Burkitt's Lymphoma;
Immunodeficiency-Related Burkitt Lymphoma;
Immunodeficiency-Related Burkitt's Lymphoma =Neoplastic Process ;
|
- 117. immune adherence reaction
- [a method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets; reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. ( CSP )] (UMLS (CSP) C0020947) =Laboratory Procedure =agglutination reaction;
| - 167. Immunodeficiency-Related Disorder
- (UMLS (NCI) C1334159) Immunodepression-Related Disorder;
Immunosuppression-Related Disorder;
=Disease or Syndrome ;
|
- 118. Immune blot
- [Molecular, Immune blot ( HL7V3.0 )] (UMLS (HL7) C1553158) =Laboratory Procedure =ObservationMethod;
| - 168. Immunodeficiency-Related Malignant Neoplasm
- (UMLS (NCI) C1334160) Immunosuppression-Related Cancer;
Immunosuppression-Related Malignancy;
Immunosuppression-Related Malignant Neoplasm =Neoplastic Process ;
|
- 119. Immune Cell Activation
- [Immune Cell Activation involves cell interaction and cell signaling mechanisms that recognize or respond to the presence of foreign antigen and that induce responsive cells of the immune system to synthesize and secrete defensive products, to proliferate, to differentiate, or to attack the sources of foreign antigens. ( NCI )] (UMLS (NCI) C1155000) leukocyte activation;
=Cell Function | - 169. Immunodeficiency-Related Neoplasm
- (UMLS (NCI) C1334161) Immunosuppression-Related Neoplasm =Neoplastic Process ;
|
- 120. immune complex disease
- [group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. ( CSP )] (UMLS (CSP) C0020951) =Disease or Syndrome =autoimmune disease;
Allergic Reaction;
Allergy;
=serum sickness;
Arthus phenomenon;
serum sickness;
HYPERSENSIT ANGIITIS NOS | - 170. immunodeficient mouse model
- [ ] (UMLS (CSP) C0599920) =Mammal ;
|
- 121. Immune Complex Glomerulonephritis
- (UMLS (NCI) C0744421) =Disease or Syndrome
| - 171. Immunodiagnosis
- (UMLS (NCI) C0021052) =Laboratory Procedure ;
|
- 122. immune disorder
- [A disorder resulting from an abnormality in the immune system. — 2003 (NCI) ( NCI )] (UMLS (CSP) C0021053) =Disease or Syndrome ;
=Diseases, Manifestations or Physiologic States;
=autoimmune disease;
blood group incompatibility;
Glomerulonephritis, Membranoproliferative;
Graft Rejection;
autoimmune foreign transplant disease;
Allergic Reaction;
hypoimmunity;
Immunoproliferative Disorders;
Purpura, Thrombocytopenic | - 172. immunodiffusion
- [technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. ( CSP )] (UMLS (CSP) C0017231) =Laboratory Procedure ;
=Immune precipitation;
|
- 123. immune globulin/ZDV
- (UMLS (NCI) C0279261) =Therapeutic or Preventive Procedure
| - 173. immunoelectroadsorption
- [ ] (UMLS (CSP) C0596752) =Laboratory Procedure =immunologic assay;
|
- 124. immune inclusion disease
- [ ] (UMLS (CSP) C0598653) =Disease or Syndrome
| - 174. immunoelectron microscopy
- [microscopy in which the samples are first stained immunocytochemically and then examined using an electron microscope. ( CSP )] (UMLS (CSP) C0079835) =Diagnostic Procedure =electron microscopy;
immunocytochemistry |
- 125. IMMUNE MECHANISM DIS NEC
- (UMLS (ICD9CM) C0398672) =Disease or Syndrome ;
| - 175. Immunoelectrophoresis
- [technique that combines protein electrophoresis and double immunodiffusion: in this procedure proteins are first separated by gel electrophoresis, then made visible by immunodiffusion of specific antibodies; a distinct elliptical precipitin arc results for each protein detectable by the antisera. ( CSP )] (UMLS (HL7) C0020997) =Laboratory Procedure ;
=electrophoresis;
immunologic technique;
ObservationMethod;
|
- 126. immune modulation
- [various processes by which antibodies may regulate immune responses; at a simple level, secreted antibody neutralizes the antigen with which it reacts thus preventing further antigenic stimulation of the antibody producing clone; at a more complex level, anti-idiotype antibodies can be shown to develop against the first antibodies in some cases and perhaps further anti-idiotype antibodies against them; this is the major concept of the immunological network theory. ( CSP )] (UMLS (CSP) C0678889) =Organism Function ;
=Immunology;
=anamnestic reaction;
immune tolerance/unresponsiveness;
antigen presentation;
| - 176. Immunoenzyme Technique
- [Immunologic technique based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens (From MESH 2001). ( NCI )] (UMLS (NCI) C0021002) =Laboratory Procedure ;
|
- 127. immune phagocytosis
- [ ] (UMLS (CSP) C0301899) =Cell Function ;
| - 177. Immunofixation
- [An enhancement of immunoelectrophoresis in which a series of post-electrophoretic gel slabs are layered with cellulose-acetate gels saturated with specific antibodies. The resulting antigen-antibody complexes fixed on the second gel may then be stained, allowing sensitive and specific qualitative visual identification of paraproteins by electrophoretic position. It can be used to identify specific proteins in the blood or urine. It has greatest application in the identification and monitoring of monoclonal proteins that are produced in conditions like Waldenstom's macroglobulinaemia and multiple myeloma. ( NCI )] (UMLS (NCI) C0430292) =Laboratory Procedure
|
- 128. Immune precipitation
- [serologic tests in which a positive reaction manifested by visible precipitation occurs when a soluble antigen reacts with its antibody. ( CSP )] (UMLS (HL7) C0021069) =Laboratory Procedure ;
=serology/serodiagnosis;
ObservationMethod =immunodiffusion;
ChIP;
| - 178. Immunofixation electrophoresis (IFE)
- [Electrophoresis, Immunofixation ( HL7V3.0 )] (UMLS (HL7) C1611269) =Laboratory Procedure ;
=ObservationMethod;
|
- 129. immune receptor
- [cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells; although these receptors were first identified in the immune system, many have important functions elsewhere; not all immunologic receptors are tree'd under this term. ( CSP )] (UMLS (CSP) C0034817) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor =Cell Surface Receptor;
=Extracellular Matrix, Integrins;
scavenger receptor;
cytokine receptor | - 179. Immunofluorescent antibody, direct
- [Immune stain, Immunofluorescent antibody, direct ( HL7V3.0 )] (UMLS (HL7) C1553147) =Laboratory Procedure =ObservationMethod;
|
- 130. immune resistance
- [ ] (UMLS (CSP) C1328910) =Physiologic Function
| - 180. Immunofluorescent antibody, indirect
- [Immune stain, Immunofluorescent antibody, indirect ( HL7V3.0 )] (UMLS (HL7) C1553148) =Laboratory Procedure =ObservationMethod;
|
- 131. immune response gene
- [specific set of MHC genes whose protein products are involved in executing the immune response; genetic diversity underlies differences in immune responses between individuals. ( CSP )] (UMLS (CSP) C0086344) =Gene or Genome =structural gene;
immunogenetics | - 181. immunogenetics
- [subdiscipline of genetics (the branch of science concerned with the means and consequences of transmission and generation of the components of biological inheritance) which deals with the genetic basis of the immune response. ( CSP )] (UMLS (CSP) C0021005) =Biomedical Occupation or Discipline ;
=Genetics;
Immunology =DNA rearrangement;
immunoglobulin gene;
immune response gene;
histocompatibility gene |
- 132. immune serum bank
- [ ] (UMLS (CSP) C0597886) =Health Care Related Organization ;
| - 182. immunogenic
- [ ] (UMLS (CSP) C0872192) =Functional Concept ;
|
- 133. Immune Surveillance
- [Immune Surveillance refers to T cell circulation through tissues and destruction of virally infected cells (and possibly cancer cells) that induce T cell activation due to expression of foreign antigens. ( NCI )] (UMLS (NCI) C0021059) =Organism Function ;
| - 183. immunoglobulin allotype
- [Allelic variants of the immunoglobulin light chains (IMMUNOGLOBULIN LIGHT CHAINS) or heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) encoded by ALLELES of IMMUNOGLOBULIN GENES. ( MSH )] (UMLS (CSP) C0021006) =Immunologic Factor ;
|
- 134. Immune System and Related Disorders
- (UMLS (NCI) C1334156) Immunodeficiency and Immunosuppression Disorders =Disease or Syndrome ;
| - 184. Immunoglobulin Binding Factor
- [Immunoglobulin Binding Proteins temporarily and non-covalently interact through physical forces of attraction and spatial complementarity with structurally-related Y-shaped monomeric or polymeric glycoproteins produced by B-lymphocytes that function as antibodies. ( NCI )] (UMLS (NCI) C1412030) Immunoglobulin Binding Protein;
=Amino Acid, Peptide, or Protein; Immunologic Factor |
- 135. Immune System Finding
- (UMLS (NCI) C1291764) =Finding ;
| - 185. immunoglobulin class switching
- [Gene rearrangement of the B-lymphocyte which results in a substitution in the type of heavy-chain constant region that is expressed. This allows the effector response to change while the antigen binding specificity (variable region) remains the same. The majority of class switching occurs by a DNA recombination event but it also can take place at the level of RNA processing. ( MSH )] (UMLS (CSP) C0206071) =Genetic Function
|
- 136. immune system surgery
- [ ] (UMLS (CSP) C1285315) =Therapeutic or Preventive Procedure
| - 186. Immunoglobulin Constant Region
- [The domains of the immunoglobulin molecules that are invariable in their amino acid sequence within any class or subclass of immunoglobulin. They confer biological as well as structural functions to immunoglobulins. One each on both the light chains and the heavy chains comprises the C-terminus half of the IMMUNOGLOBULIN FAB FRAGMENT and two or three of them make up the rest of the heavy chains (all of the IMMUNOGLOBULIN FC FRAGMENT) ( MSH )] (UMLS (NCI) C0021008) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 137. immune system tolerance
- [The failure of the immune system to respond to an antigen that previously caused an immune response. ( NCI )] (UMLS (NCI) C0020963) =Pathologic Function
| - 187. Immunoglobulin Deposition Disease
- [A plasma cell neoplasm that secretes an abnormal immunoglobulin, which deposits in tissues and forms a beta-pleated sheet structure that binds Congo red dye with characteristic birefringence. (WHO, 2001) ( NCI )] (UMLS (NCI) C0268381) =Disease or Syndrome ;
|
- 138. IMMUNE THROMBOCYT PURPRA
- (UMLS (ICD9CM) C0398650) =Disease or Syndrome ;
| - 188. Immunoglobulin Family Gene
- [Immunoglobulin Family Genes encode structurally-related Immunoglobulin Family Proteins containing one, or more, 100-aa Immunoglobulin domain that includes a conserved intradomain disulfide bond and may be involved in protein-protein or protein-ligand interactions. Immunoglobulin Family members include hundreds of functionally diverse proteins, such as Immunoglobulins, the muscle kinase titin, and receptor tyrosine kinases. (NCI) ( NCI )] (UMLS (NCI) C1334163) =Gene or Genome ;
|
- 139. immune tolerance/unresponsiveness
- [failure to respond to contact with antigen; may be specific for a given antigen (tolerance) or generalized to many antigens, as in immunodeficiency states. ( CSP )] (UMLS (CSP) C0178709) =Disease or Syndrome =immunity;
immune modulation;
immunopathology;
=immunosuppression;
anergy;
oral tolerance;
| - 189. Immunoglobulin Family Protein
- [Encoded by Immunoglobulin Family Genes, structurally-related Immunoglobulin Family Proteins contain one, or more, 100-aa Immunoglobulin domain that includes a conserved intradomain disulfide bond and may be involved in protein-protein or protein-ligand interactions. Immunoglobulin Family members include hundreds of functionally diverse proteins, such as Immunoglobulins, the muscle kinase titin, and receptor tyrosine kinases. (NCI) ( NCI )] (UMLS (NCI) C1334164) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 140. immunity
- [nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. ( CSP )] (UMLS (CSP) C0020964) =Physiologic Function =Immunology;
=antigen antibody reaction;
Autoimmune Status;
Cell Mediated Immunity;
Humoral Immunity;
anamnestic reaction;
bactericidal immunity;
cross immunity;
immune tolerance/unresponsiveness;
cell mediated cytotoxicity;
| - 190. immunoglobulin gene
- [genes encoding the light and heavy chain segments of immunoglobulins; these genes undergo several DNA rearrangements during the differentiation of stem cells into B cells and plasma cells, permitting synthesis of the various immunoglobulin classes. ( CSP )] (UMLS (CSP) C0017350) =Gene or Genome =structural gene;
immunogenetics |
- 141. immunization
- [deliberate induction of host immunity. ( CSP )] (UMLS (CSP) C0020971) =Therapeutic or Preventive Procedure ;
=communicable disease control;
chemotherapy;
immunologic technique;
Immunologically Directed Therapy =Passive Immunization;
Active Immunization;
hyperimmunization;
Booster Immunization;
Initial Immunization;
| - 191. immunoglobulin gene control
- [ ] (UMLS (CSP) C0598662) =Genetic Function
|
- 142. immunization
- [A technique used to cause an immune response that results in resistance to a specific disease, especially an infectious disease. ( NCI )] (UMLS (NCI) C1368825) =Therapeutic or Preventive Procedure
| - 192. immunoglobulin genetic recombination mechanism
- [ ] (UMLS (CSP) C1328911) =Genetic Function
|
- 143. immunization category
- [ Definition:All information pertaining to a patient's vaccination records. ( HL7V3.0 )] (UMLS (HL7) C1698056) =Classification ;
=ActCode;
| - 193. Immunoglobulin Heavy Chain
- [A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions. ( NCI )] (UMLS (NCI) C0021034) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 144. Immunization Registry Status
- (UMLS (HL7) C1547821) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Inactive - Lost to follow-up (cancel contract);
Inactive - Moved or gone elsewhere (cancel contract);
Inactive - Permanently inactive (Do not reactivate or add new entries to the record);
Other;
Unknown;
Active;
Inactive;
| - 194. Immunoglobulin Heavy Chain Deletion
- (UMLS (NCI) C0398692) =Disease or Syndrome ;
|
- 145. Immunization/preventive medication
- (UMLS (ICPC) C0497105) (Immunization/preventive medication; txertaketak/aurrezaintzako medikazioa; Vacc/forebyggende medicinering; Immunisatie/preventieve medicatie; ROKOTUS/ ENNALTAEHKAISEVA LAAKITYS; Vaccination/medication prevent; Impfung/praeventive Medikation; (108); oltas/preventiv gyogyszereles; Immunizzaz/somm prevent farmaci; FOREBYGGENDE VAKSINERING/MEDIKASJ; Vacinacao/medicacao preventiva; Farmacos/inmunizaciones prevent; IMMUNISERING/PREVENTIV MEDICINERING) Immunization/prevent medication =Therapeutic or Preventive Procedure =Diagnostic and Preventive Procedures Component;
| - 195. Immunoglobulin Hinge Region
- [A region of relative flexibility between the variable and constant regions of an antibody molecule. ( NCI )] (UMLS (NCI) C0312783) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 146. Immuno International AG
- [Immuno International AG ( HL7V3.0 )] (UMLS (HL7) C1546872) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
VaccineManufacturer | - 196. immunoglobulin isotype
- [classes of immunoglobulins found in any species of animal; in man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties. ( CSP )] (UMLS (CSP) C0021017) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=[IM500] IMMUNOGLOBULINS;
|
- 147. Immuno-U.S., Inc.
- [Immuno-U.S., Inc. ( HL7V3.0 )] (UMLS (HL7) C1546874) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
VaccineManufacturer | - 197. Immunoglobulin Joining Region
- [A segment of the immunoglobulin heavy chains, encoded by the IMMUNOGLOBULIN HEAVY CHAIN GENES in the J segment where, during the maturation of B-LYMPHOCYTES; the gene segment for the variable region upstream is joined to a constant region gene segment downstream. The exact position of joining of the two gene segments is variable and contributes to ANTIBODY DIVERSITY. It is distinguished from the IMMUNOGLOBULIN, J CHAINS; a separate polypeptide that serves as a linkage piece in polymeric IGA or IGM. ( MSH )] (UMLS (NCI) C0021018) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 148. immunoaffinity chromatography
- [affinity chromatography using monoclonal or polyclonal antibodies, or (less commonly) antigens, as the immobilized binding phase. ( CSP )] (UMLS (CSP) C0596751) =Laboratory Procedure ;
=affinity chromatography;
immunologic technique | - 198. Immunoglobulin Light Chain
- [A protein complex that consists of two light chains (kappa and lambda). The light chain molecules are of the same structure and composition, consisting of constant, variable, and hypervariable regions. ( NCI )] (UMLS (NCI) C0021038) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 149. immunoassay
- [Immunoassay ( HL7V3.0 )] (UMLS (CSP) C0020980) =Laboratory Procedure ;
=ObservationMethod;
| - 199. immunoglobulin light chain locus
- [ ] (UMLS (CSP) C1328912) =Gene or Genome
|
- 150. Immunoassay, qualitative, multiple step
- [Immunoassay, qualitative, multiple step ( HL7V3.0 )] (UMLS (HL7) C0523399) =Laboratory Procedure =ObservationMethod;
| - 200. Immunoglobulin Light Chain, Kappa
- [Immunoglobulin Light Chain Kappa is one of two Ig light chain types. Each Ig molecule is typically composed of two heavy chains and two light chains. Ig kappa light chains contain a variable and a constant region. Kappa light chains are encoded by multiple V, J, and C gene segments, which are separated in the genomes of cells undifferentiated with regard to antibody gene expression. Diversity in the kappa light chain V region arises during differentiation of an activated (kappa-type) antibody-producing B-cell from variable recombination of kappa V genes with kappa J genes and somatic point mutation, which plays a major role in antibody diversity. (from OMIM and NCI) ( NCI )] (UMLS (NCI) C0021036) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
home
